What is UTHR's five-year median EV/Sales?

4.7x. Half of UTHR's weekly readings over the last five years were higher and half were lower. This page has 809 weekly readings, from Apr 25, 2011 to Oct 19, 2026.

Does a low historical rank mean a stock is a buy?

No. The rank compares UTHR only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.

United Therapeutics Corp (UTHR) valuation history

Health Care

$587.50

Latest weekly close · Market cap $26.9B

Historically high

As of Oct 24, 2026

UTHR's EV/Sales of 7.7x is higher than 98% of its weekly readings over the last five years.

Weekly EV/Sales with its 5-year range

EV/Sales each weekMiddle half of the last 5 years5-year median 4.7×

5-year median: 4.7×
10-year median: 3.8×
5-year low to high: 3.5×–7.9×
Versus 5-year median: +64%

EV/Sales

98thpercentile

of its weekly readings over the last five years

Historically high

Growth, last 12 months vs the year before

Revenue: +2%slowing
EPS: +9%

Price vs revenue and EPS, indexed to 100

Each line starts at 100 at its first positive reading over the last five years. Revenue and EPS change at fiscal quarter ends.

PriceRevenue, last 12 monthsEPS, last 12 months100 = first reading

EV/Sales at each year-end

The last weekly reading of each year, and its percentile against the five years before it.

UTHR EV/Sales at each year-end
Year-end	EV/Sales	5-year percentile
Dec 29, 2025	6.6×	99
Dec 30, 2024	5.1×	82
Dec 25, 2023	3.7×	41
Dec 26, 2022	5.9×	98
Dec 27, 2021	5.0×	98
Dec 28, 2020	3.7×	92
Dec 30, 2019	1.5×	9
Dec 31, 2018	2.2×	4
Dec 25, 2017	3.2×	25
Dec 26, 2016	3.6×	32

Health Care peers on EV/Sales

Each percentile compares a stock with its own last five years.

Compare UTHR with peers

Health Care peers of UTHR on EV/Sales
Stock	EV/Sales	Versus its own history	5-year percentile
ABBVAbbVie	8.7×	Historically high	100
AMGNAmgen	7.5×	Historically high	96
ARWRArrowhead Pharmaceuticals Inc	11.1×	Below its usual range	29
BBIOBridgebio Pharma Inc	21.5×	Below its usual range	24
BIIBBiogen	4.3×	Historically high	96

Appears in

Sector: Health Care
Screens: Stocks with Low P/E Ratios and Steady Revenue Growth
Stocks Below Their 5-Year Median P/E
Stocks Near Their Lowest P/E Ratios in 5 Years

Screen Health Care stocks the same way

Research on UTHR

No articles about UTHR yet. How valuation percentiles work

Loading peers and related research…

About this history

What is UTHR's current EV/Sales?: UTHR's EV/Sales of 7.7x is higher than 98% of its weekly readings over the last five years.
What is UTHR's five-year median EV/Sales?: 4.7x. Half of UTHR's weekly readings over the last five years were higher and half were lower. This page has 809 weekly readings, from Apr 25, 2011 to Oct 19, 2026.
Does a low historical rank mean a stock is a buy?: No. The rank compares UTHR only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.